Integral Diagnostics Updates Dividend Notification for FY26
Integral Diagnostics Ltd., an Australian healthcare company providing diagnostic imaging services through a network of clinics and medical facilities, has updated its earlier dividend notification to clarify the foreign exchange rate used to convert its Australian dollar-denominated dividend into New Zealand dollars. The update relates to a six-month period ending 30 June 2026.
The company's ordinary fully paid shares form the basis for its shareholder distributions, reflecting its position as a healthcare services issuer in the listed equity market. Integral Diagnostics has confirmed the share price applied under its dividend reinvestment plan and provided additional transparency for shareholders on the mechanics and valuation of the upcoming dividend payment.
The company's update comes as analysts remain optimistic about its prospects, with the most recent rating on (AU:IDX) stock being a Buy with an A$3.20 price target.